Leslie Holsinger - EVP, Preclinical Development at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Preclinical Development
Stock Symbol
QNCX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Leslie Holsinger since 10/6/2023

Holdings reported by Leslie Holsinger for Quince Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 148K $139K $0.94 Jun 6, 2022 Direct

Transactions reported by Leslie Holsinger for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.